The effects of topical calcipotriol on systemic calcium homeostasis in patients with chronic plaque psoriasis
Authors:
- R. MumfordaRMR. Mumforda
- P. Whittaker BPBP. Whittaker B
- S.J. IqbalbSIS.J. Iqbalb
- L.W. Le VandLVL.W. Le Vand
- A. Trevellyan CACA. Trevellyan C
- P.E. HutchinsonaPHP.E. Hutchinsona
- 1 December 1997
- journal article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 37 (6) , 929-934
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- High dose topical calcipotriol consistently reduces serum parathyroid hormone levelsClinical Endocrinology, 1994
- Hypercalcaemia during treatment of psoriasis with calcipotriplBritish Journal of Dermatology, 1994
- Urine calcium excretion during treatment of psoriasis with topical calcipotriolBritish Journal of Dermatology, 1993
- High-dose topical calcipotriol in the treatment of extensive psoriasis vulgarisBritish Journal of Dermatology, 1993
- Hypercalcaemia with topical calcipotriol.BMJ, 1993
- Hypercalcaemia associated with calcipotriol (Dovonex) treatment.BMJ, 1993
- A multicentre, parallel-group comparison of calcipotriol ointment and short-contact dithranol therapy in chronic plaque psoriasisBritish Journal of Dermatology, 1992
- Comparative study of calcipotriol (MC 903) ointment and betamethasone 17-valerate ointment in patients with psoriasis vulgarisJournal of the American Academy of Dermatology, 1992
- Double-blind, right/left comparison of calcipotriol and betamethasone valerate in treatment of psoriasis vulgarisThe Lancet, 1991
- Effects of a novel vitamin D analogue MC 903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivoBiochemical Pharmacology, 1988